epigallocatechin gallate has been researched along with tamoxifen in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 10 (43.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casciano, CN; Clement, RP; Johnson, WW; Wang, EJ | 1 |
| Bhimani, RS; Frenkel, K; Grunberger, D; Troll, W | 1 |
| Frenkel, K; Wei, H | 1 |
| Fujiki, H; Iida, N; Kim, SJ; Komori, A; Okabe, S; Sueoka, E; Suganuma, M | 1 |
| Fujiki, H; Kai, Y; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
| Aiello, FB; Brunetti, M; Caltagirone, S; Natali, PG; Piantelli, M; Poggi, A; Ranelletti, FO; Rossi, C | 1 |
| Rosengren, RJ | 1 |
| Bray, BJ; Chisholm, K; Rosengren, RJ | 1 |
| Larsen, L; Rosengren, RJ; Stuart, EC | 1 |
| Barbi, C; Farabegoli, F; Lambertini, E; Piva, R | 1 |
| Menon, S; Patel, R; Pawar, V; Shervington, A; Thakkar, D | 1 |
| Menzies, AR; Rosengren, RJ; Scandlyn, MJ; Somers-Edgar, TJ; Stuart, EC | 1 |
| Choi, JS; Shin, SC | 1 |
| Bartolini, G; Farabegoli, F; Orlandi, M; Ostan, R; Papi, A | 1 |
| Farabegoli, F; Orlandi, M; Papi, A | 1 |
| Li, Y; Meeran, SM; Tollefsbol, TO; Yuan, YY | 1 |
| Fukazawa, H; Murakami, Y; Suzuki, T; Wakita, T | 1 |
| Chen, Y; Guo, SW; Liu, X; Zhang, H; Zhu, B | 1 |
| Faratian, D; Harrison, DJ; Huang, R; Langdon, SP; Sims, AH; Thomas, JS; Wilson, D | 1 |
| Li, Y; Meeran, SM; Tollefsbol, TO | 1 |
| Dostal, AM; Emory, TH; Kurzer, MS; Le, CT; Lee, E; Samavat, H; Swenson, K; Torkelson, CJ; Ursin, G; Wang, R; Wu, AH; Yang, CS; Yee, D; Yu, MC; Yuan, JM | 1 |
| Das, SK; Emdad, L; Fisher, PB; Kumar, BNP; Kundu, SC; Mahto, MK; Mandal, M; Pathak, A; Puvvada, N; Rajput, S; Reis, RL; Sarkar, S; Yallapu, MM | 1 |
| Heidegger, H; Hofmann, S; Jeschke, U; Koch, JG; Mahner, S; Marahrens, P; Phan-Brehm, T; Richter, DU; Schröder, L; Vilsmeier, T | 1 |
1 review(s) available for epigallocatechin gallate and tamoxifen
| Article | Year |
|---|---|
Catechins and the treatment of breast cancer: possible utility and mechanistic targets.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Female; Humans; Tamoxifen; Tea | 2003 |
1 trial(s) available for epigallocatechin gallate and tamoxifen
| Article | Year |
|---|---|
A Randomized Controlled Trial of Green Tea Extract Supplementation and Mammographic Density in Postmenopausal Women at Increased Risk of Breast Cancer.
Topics: Aged; Anticarcinogenic Agents; Antioxidants; Body Mass Index; Breast; Breast Density; Breast Neoplasms; Catechin; Catechol O-Methyltransferase; Dietary Supplements; Double-Blind Method; Female; Genotype; Humans; Mammography; Middle Aged; Plant Extracts; Postmenopause; Tamoxifen; Tea | 2017 |
21 other study(ies) available for epigallocatechin gallate and tamoxifen
| Article | Year |
|---|---|
Fluorescent substrates of sister-P-glycoprotein (BSEP) evaluated as markers of active transport and inhibition: evidence for contingent unequal binding sites.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Binding Sites; Biological Transport, Active; Biomarkers; Cells, Cultured; Drug Interactions; Fluorescent Dyes; Humans | 2003 |
Inhibition of oxidative stress in HeLa cells by chemopreventive agents.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Anticarcinogenic Agents; Antineoplastic Agents; Caffeic Acids; Catechin; Deoxyguanosine; Diterpenes; DNA, Neoplasm; HeLa Cells; Humans; Hydrogen Peroxide; Hydrolyzable Tannins; Oxidation-Reduction; Phenylethyl Alcohol; Tamoxifen; Tannins; Tetradecanoylphorbol Acetate; Thymidine | 1993 |
Relationship of oxidative events and DNA oxidation in SENCAR mice to in vivo promoting activity of phorbol ester-type tumor promoters.
Topics: Animals; Carcinogens; Catechin; Diterpenes; DNA; DNA Damage; Female; Hydrogen Peroxide; Inflammation; Mice; Mice, Inbred Strains; Neutrophils; Oxidation-Reduction; Phorbol Esters; Skin; Tamoxifen; Terpenes; Tetradecanoylphorbol Acetate | 1993 |
A new process of cancer prevention mediated through inhibition of tumor necrosis factor alpha expression.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Base Sequence; Catechin; Cyclohexanols; Diterpenes; Humans; Mice; Molecular Sequence Data; Proto-Oncogenes; Tamoxifen; Tumor Necrosis Factor-alpha | 1996 |
Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lung Neoplasms; Mice; Sulindac; Tamoxifen; Tea; Tumor Cells, Cultured | 1999 |
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential.
Topics: Animals; Anticarcinogenic Agents; Apigenin; Catechin; Cell Division; Curcumin; Female; Flavonoids; Growth Inhibitors; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasm Invasiveness; Neoplasm Transplantation; Quercetin; Resveratrol; Stilbenes; Tamoxifen; Tumor Cells, Cultured | 2000 |
Tamoxifen and epigallocatechin gallate are synergistically cytotoxic to MDA-MB-231 human breast cancer cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Synergism; Humans; Tamoxifen | 2004 |
Potential mechanisms for the synergistic cytotoxicity elicited by 4-hydroxytamoxifen and epigallocatechin gallate in MDA-MB-231 cells.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Humans; Tamoxifen | 2007 |
(-)-Epigallocatechin-3-gallate downregulates estrogen receptor alpha function in MCF-7 breast carcinoma cells.
Topics: Anticarcinogenic Agents; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Down-Regulation; Estrogen Receptor alpha; Female; Humans; Tamoxifen; Trefoil Factor-1; Tumor Suppressor Proteins | 2007 |
The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.
Topics: Antineoplastic Agents; Catechin; Cell Death; Cell Line, Tumor; Cell Survival; Cisplatin; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Glioma; Humans; Tamoxifen; Telomerase | 2009 |
A new role for tamoxifen in oestrogen receptor-negative breast cancer when it is combined with epigallocatechin gallate.
Topics: Animals; Antineoplastic Agents, Hormonal; Aryl Hydrocarbon Hydroxylases; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Cytochrome P-450 CYP1B1; Down-Regulation; Drug Therapy, Combination; ErbB Receptors; Female; Humans; Mice; Mice, Nude; Protein Kinases; Receptors, Estrogen; Tamoxifen; TOR Serine-Threonine Kinases; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1 | 2008 |
Effects of epigallocatechin gallate on the oral bioavailability and pharmacokinetics of tamoxifen and its main metabolite, 4-hydroxytamoxifen, in rats.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Hormonal; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Catechin; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Injections, Intravenous; Intestinal Mucosa; Liver; Male; Rats; Rats, Sprague-Dawley; Tamoxifen | 2009 |
(-)-Epigallocatechin-3-gallate downregulates Pg-P and BCRP in a tamoxifen resistant MCF-7 cell line.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; bcl-2-Associated X Protein; Breast Neoplasms; Camellia sinensis; Catechin; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Resistance, Neoplasm; Gene Expression; Humans; Leupeptins; Mitoxantrone; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Plant Extracts; Protease Inhibitors; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger; Tamoxifen | 2010 |
(-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
Topics: Basigin; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Down-Regulation; Drug Resistance, Neoplasm; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Female; Gene Expression; Humans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Phosphorylation; RNA, Messenger; Signal Transduction; Tamoxifen; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2 | 2011 |
Synergistic epigenetic reactivation of estrogen receptor-α (ERα) by combined green tea polyphenol and histone deacetylase inhibitor in ERα-negative breast cancer cells.
Topics: Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Survival; Chromatin Immunoprecipitation; DNA Methylation; Drug Synergism; Estrogen Receptor alpha; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Polymerase Chain Reaction; Promoter Regions, Genetic; Tamoxifen | 2010 |
A cell-based, microplate colorimetric screen identifies 7,8-benzoflavone and green tea gallate catechins as inhibitors of the hepatitis C virus.
Topics: Antiviral Agents; Benzoflavones; Camellia sinensis; Catechin; Cell Line, Tumor; Cyclosporine; Drug Evaluation, Preclinical; Flavones; Hepacivirus; Hepatitis C; Humans; Phytotherapy; Reproducibility of Results; Tamoxifen | 2012 |
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.
Topics: Adenomyosis; Animals; Biomarkers; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Hydrocortisone; Hyperalgesia; Mice; Mice, Inbred ICR; Myometrium; Pain Threshold; Reaction Time; Stress, Physiological; Tamoxifen; Time Factors; Uterine Contraction | 2013 |
Increased STAT1 signaling in endocrine-resistant breast cancer.
Topics: Blotting, Western; Breast Neoplasms; Catechin; Cell Survival; Cyclic S-Oxides; Estrogens; Female; Humans; MCF-7 Cells; Polymerase Chain Reaction; Pyridines; STAT1 Transcription Factor; STAT3 Transcription Factor; Tamoxifen; Tyrphostins | 2014 |
Combinatorial bioactive botanicals re-sensitize tamoxifen treatment in ER-negative breast cancer via epigenetic reactivation of ERα expression.
Topics: Animals; Antineoplastic Agents, Hormonal; Breast Neoplasms; Catechin; Cell Line, Tumor; Disease Models, Animal; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Epigenesis, Genetic; Estrogen Receptor alpha; Heterografts; Humans; Isothiocyanates; Mice; Neoplasm Transplantation; Phytochemicals; Sulfoxides; Tamoxifen; Treatment Outcome | 2017 |
Targeting of EGFR, VEGFR2, and Akt by Engineered Dual Drug Encapsulated Mesoporous Silica-Gold Nanoclusters Sensitizes Tamoxifen-Resistant Breast Cancer.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Chemical Engineering; Drug Carriers; Drug Resistance, Neoplasm; ErbB Receptors; Female; Gold; Humans; Metal Nanoparticles; Mice, Nude; Piperidines; Porosity; Proto-Oncogene Proteins c-akt; Quinazolines; Silicon Dioxide; Tamoxifen; Treatment Outcome; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2018 |
Effects of green tea, matcha tea and their components epigallocatechin gallate and quercetin on MCF‑7 and MDA-MB-231 breast carcinoma cells.
Topics: Anticarcinogenic Agents; Antioxidants; Breast Neoplasms; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Female; Humans; MCF-7 Cells; Quercetin; Receptors, Estrogen; Tamoxifen; Tea | 2019 |